Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42284409.
- Also identified by DOI 10.1126/sciadv.adv2687 and PMC identifier 13262618.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
MHC-I proteins present epitopic peptides to CD8<sup>+</sup> T cells to elicit multifaceted adaptive immune responses. The affinity and avidity of interactions between peptide-MHC molecules and their cognate T cell receptors (TCRs) are fundamental parameters that contribute to the induction of activated or anergic T cell states. Here, we present a multivalent, loadable platform, VLP-Open HLA, featuring a virus-like particle (VLP) which can display up to 60 peptide/HLA [human leukocyte antigen (HLA)] molecules. VLP-Open HLA can be used to stain antigen-specific CD8<sup>+</sup> T cells, providing a screening tool for orphan TCRs. When combined with costimulation, VLP-Open HLA acts as an artificial antigen-presenting platform to induce antigen-specific T cell activation and expansion, providing a facile alternative to autologous antigen-presenting cells. Our platform can be adapted to encompass multiple HLA allotypes and costimulatory molecules as mosaic nanoparticles, enabling a range of applications in experimental immunology.
Medical subject headings
- Nanoparticles
- Histocompatibility Antigens Class I
- CD8-Positive T-Lymphocytes
- High-Throughput Screening Assays
- T-Lymphocytes